
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
[ Tue, Feb 01st 2022 ]: WOPRAI
Marc Goodman Initiated (AMLX) at Buy and Held Target at $50 on, Feb 1st, 2022


🞛 This publication is a summary or evaluation of another publication
Marc Goodman of SVB Leerink, Initiated "Amylyx Pharmaceuticals, Inc." (AMLX) at Buy and Held Target at $50 on, Feb 1st, 2022.
Marc, nor any peers, have made any analyst calls on AMLX in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30